ASTRAZENECA PLC
Related Filers (41)
- ALEXION PHARMACEUTICALS, INC. (38)
- PFIZER INC (21)
- BlackRock Inc. (17)
- CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC (15)
- WELLINGTON MANAGEMENT GROUP LLP (8)
- CAPITAL RESEARCH & MANAGEMENT CO (7)
- NEW YORK STOCK EXCHANGE LLC (7)
- CAPITAL GROUP INTERNATIONAL INC (6)
- ASTRAZENECA AB (6)
- Nasdaq Stock Market LLC (6)
- AstraZeneca Finance LLC (6)
- Viela Bio, Inc. (5)
- CinCor Pharma, Inc. (5)
- Icosavax, Inc. (5)
- AstraZeneca UK LTD (4)
- Regulus Therapeutics Inc. (4)
- ALBIREO PHARMA, INC. (4)
- Entasis Therapeutics Holdings Inc. (4)
- Ardea Biosciences, Inc./DE (3)
- Citibank,N.A./ADR (3)
- PhaseBio Pharmaceuticals Inc (3)
- Aevi Genomic Medicine, Inc. (3)
- MERRILL LYNCH & CO INC (2)
- INVESTOR AB (2)
- JPMorgan Chase Bank, N.A. - ADR Depositary (2)
- APPLIED GENETIC TECHNOLOGIES CORP (2)
- Zeneca, Inc. (2)
- MedImmune Ltd (2)
- ADC Therapeutics SA (2)
- Moderna, Inc. (2)
- PIERIS PHARMACEUTICALS, INC. (2)
- Deutsche Bank Trust Co Americas/ ADR Group (2)
- Aridis Pharmaceuticals, Inc. (2)
- Cellectis S.A. (2)
- CANCERVAX CORP (1)
- MEDIMMUNE INC /DE (1)
- INOTEK PHARMACEUTICALS CORP (1)
- CATABASIS PHARMACEUTICALS INC (1)
- G1 Therapeutics, Inc. (1)
- Innate Pharma SA (1)
- SARIN ARADHANA (1)
- Show More ...
Other (1478)
6-K
Thursday, 2/8/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/1/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 1/19/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/2/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/22/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 12/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/12/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/12/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/24/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/17/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
25-NSE
Tuesday, 11/14/2023
Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
6-K
Tuesday, 11/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Monday, 11/13/2023
Filing for proposed sale of securities under Rule 144
6-K
Thursday, 11/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 10/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/2/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/25/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 9/15/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 9/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
25-NSE
Wednesday, 8/16/2023
Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
6-K
Tuesday, 8/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/17/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
11-K
Wednesday, 6/28/2023
Annual report of employee stock purchase, savings and similar plans
6-K
Friday, 6/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/2/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
25-NSE
Thursday, 5/25/2023
Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
6-K
Monday, 5/22/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/17/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/2/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/2/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/2/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 4/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/5/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 4/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 4/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 3/22/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 3/22/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CERT
Wednesday, 3/15/2023
Certification by an exchange approving securities for listing
8-A12B
Monday, 3/13/2023
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
6-K
Thursday, 3/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 3/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 3/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 3/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 3/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 3/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/24/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/24/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/24/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 2/22/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Tuesday, 2/21/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Tuesday, 2/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 2/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
IRANNOTICE
Tuesday, 2/21/2023
Notice of disclosure filed in Exchange Act quarterly and annual reports pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
6-K
Monday, 2/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 2/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 2/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 1/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/17/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 1/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/30/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/21/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/21/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Ownership (88)
SC 13G/A
Monday, 2/12/2024
ADC Therapeutics SA: Major Shareholders
SC 13G/A
Wednesday, 1/24/2024
BlackRock Inc.: Major Shareholders
SC 13D/A
Thursday, 11/16/2023
Cellectis S.A.: Major Shareholders
SC 13D
Thursday, 11/9/2023
Cellectis S.A.: Major Shareholders
SC 13G/A
Friday, 2/10/2023
Aridis Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Friday, 2/10/2023
PIERIS PHARMACEUTICALS, INC.: Major Shareholders
SC 13G/A
Tuesday, 1/24/2023
BlackRock Inc.: Major Shareholders
SC 13G
Friday, 7/8/2022
BlackRock Inc.: Major Shareholders
SC 13G/A
Monday, 2/7/2022
BlackRock Inc.: Major Shareholders
SC 13G/A
Friday, 2/4/2022
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13G
Tuesday, 7/27/2021
Aridis Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Thursday, 4/8/2021
PIERIS PHARMACEUTICALS, INC.: Major Shareholders
4
Tuesday, 3/16/2021
Viela Bio, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Wednesday, 2/10/2021
Moderna, Inc.: Major Shareholders
SC 13G
Wednesday, 2/10/2021
ADC Therapeutics SA: Major Shareholders
SC 13G/A
Wednesday, 2/3/2021
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13G/A
Friday, 1/29/2021
BlackRock Inc.: Major Shareholders
4
Friday, 2/7/2020
Aevi Genomic Medicine, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 2/7/2020
Aevi Genomic Medicine, Inc.: Initial statement of beneficial ownership of securities
SC 13D
Friday, 2/7/2020
Aevi Genomic Medicine, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/5/2020
BlackRock Inc.: Major Shareholders
SC 13G
Thursday, 1/30/2020
Viela Bio, Inc.: Major Shareholders
SC 13G/A
Monday, 1/27/2020
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13D
Friday, 10/25/2019
Innate Pharma SA: Major Shareholders
4
Wednesday, 10/9/2019
Viela Bio, Inc.: Statement of changes in beneficial ownership of securities
3/A
Wednesday, 10/9/2019
Viela Bio, Inc.: Initial statement of beneficial ownership of securities
3
Wednesday, 10/2/2019
Viela Bio, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Tuesday, 2/12/2019
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13G/A
Monday, 2/4/2019
BlackRock Inc.: Major Shareholders
SC 13G
Wednesday, 1/30/2019
Moderna, Inc.: Major Shareholders
SC 13D
Monday, 10/29/2018
PhaseBio Pharmaceuticals Inc: Major Shareholders
4
Wednesday, 10/24/2018
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/17/2018
PhaseBio Pharmaceuticals Inc: Initial statement of beneficial ownership of securities
SC 13D/A
Friday, 10/12/2018
Entasis Therapeutics Holdings Inc.: Major Shareholders
SC 13D
Friday, 10/5/2018
Entasis Therapeutics Holdings Inc.: Major Shareholders
4
Tuesday, 10/2/2018
Entasis Therapeutics Holdings Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/25/2018
Entasis Therapeutics Holdings Inc.: Initial statement of beneficial ownership of securities
SC 13G
Thursday, 2/8/2018
G1 Therapeutics, Inc.: Major Shareholders
SC 13G/A
Thursday, 2/8/2018
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13G/A
Tuesday, 1/30/2018
BlackRock Inc.: Major Shareholders
SC 13D/A
Monday, 12/11/2017
ALBIREO PHARMA, INC.: Major Shareholders
4
Tuesday, 12/5/2017
ALBIREO PHARMA, INC.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 2/10/2017
CATABASIS PHARMACEUTICALS INC: Major Shareholders
SC 13G/A
Thursday, 2/9/2017
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13G/A
Thursday, 1/19/2017
BlackRock Inc.: Major Shareholders
SC 13D
Monday, 11/14/2016
ALBIREO PHARMA, INC.: Major Shareholders
3
Monday, 11/7/2016
ALBIREO PHARMA, INC.: Initial statement of beneficial ownership of securities
SC 13G
Tuesday, 2/16/2016
INOTEK PHARMACEUTICALS CORP: Major Shareholders
SC 13G/A
Thursday, 2/11/2016
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13G/A
Wednesday, 2/10/2016
BlackRock Inc.: Major Shareholders
SC 13G/A
Friday, 2/5/2016
APPLIED GENETIC TECHNOLOGIES CORP: Major Shareholders
SC 13G/A
Monday, 1/25/2016
BlackRock Inc.: Major Shareholders
SC 13G
Tuesday, 2/17/2015
APPLIED GENETIC TECHNOLOGIES CORP: Major Shareholders
SC 13G
Thursday, 2/12/2015
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13G/A
Thursday, 1/22/2015
BlackRock Inc.: Major Shareholders
SC 13G/A
Friday, 1/9/2015
Regulus Therapeutics Inc.: Major Shareholders
4
Friday, 11/14/2014
Regulus Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/11/2014
BlackRock Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/6/2013
BlackRock Inc.: Major Shareholders
3
Friday, 10/12/2012
Regulus Therapeutics Inc.: Initial statement of beneficial ownership of securities
SC 13G
Friday, 10/12/2012
Regulus Therapeutics Inc.: Major Shareholders
SC 13D/A
Tuesday, 6/19/2012
Ardea Biosciences, Inc./DE: Major Shareholders
SC 13D
Tuesday, 5/1/2012
Ardea Biosciences, Inc./DE: Major Shareholders
3
Tuesday, 5/1/2012
Ardea Biosciences, Inc./DE: Initial statement of beneficial ownership of securities
SC 13G/A
Monday, 2/13/2012
BlackRock Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/2/2011
BlackRock Inc.: Major Shareholders
SC 13G
Friday, 1/29/2010
BlackRock Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/13/2008
CAPITAL RESEARCH & MANAGEMENT CO: Major Shareholders
SC 13G/A
Tuesday, 2/12/2008
CAPITAL GROUP INTERNATIONAL INC: Major Shareholders
SC 13D
Wednesday, 6/13/2007
MEDIMMUNE INC /DE: Major Shareholders
SC 13G/A
Monday, 2/12/2007
CAPITAL RESEARCH & MANAGEMENT CO: Major Shareholders
SC 13G/A
Monday, 2/12/2007
CAPITAL GROUP INTERNATIONAL INC: Major Shareholders
SC 13D/A
Monday, 5/15/2006
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC: Major Shareholders
SC 13G/A
Friday, 2/10/2006
CAPITAL RESEARCH & MANAGEMENT CO: Major Shareholders
SC 13G/A
Thursday, 2/9/2006
CAPITAL GROUP INTERNATIONAL INC: Major Shareholders
SC 13G/A
Friday, 2/11/2005
CAPITAL RESEARCH & MANAGEMENT CO: Major Shareholders
SC 13G/A
Friday, 2/11/2005
CAPITAL GROUP INTERNATIONAL INC: Major Shareholders
SC 13D
Monday, 12/27/2004
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC: Major Shareholders
SC 13D/A
Tuesday, 2/17/2004
INVESTOR AB: Major Shareholders
SC 13G/A
Friday, 2/13/2004
CAPITAL RESEARCH & MANAGEMENT CO: Major Shareholders
SC 13G/A
Friday, 2/13/2004
CAPITAL GROUP INTERNATIONAL INC: Major Shareholders
SC 13G
Friday, 11/14/2003
CANCERVAX CORP: Major Shareholders
SC 13G/A
Thursday, 2/13/2003
CAPITAL RESEARCH & MANAGEMENT CO: Major Shareholders
SC 13G
Tuesday, 2/11/2003
CAPITAL GROUP INTERNATIONAL INC: Major Shareholders
SC 13D
Monday, 7/8/2002
INVESTOR AB: Major Shareholders
SC 13G
Friday, 2/15/2002
CAPITAL RESEARCH & MANAGEMENT CO: Major Shareholders
SC 13G/A
Friday, 2/4/2000
MERRILL LYNCH & CO INC: Major Shareholders
SC 13G
Friday, 2/5/1999
MERRILL LYNCH & CO INC: Major Shareholders
Prospectus (121)
SC TO-T/A
Thursday, 2/15/2024
Third party tender offer statement
SC TO-T/A
Friday, 1/19/2024
Third party tender offer statement
SC TO-T/A
Thursday, 1/11/2024
Third party tender offer statement
SC TO-T
Wednesday, 12/27/2023
Third party tender offer statement
SC TO-C
Tuesday, 12/12/2023
Written communication relating to an issuer or third party tender offer
424B2
Thursday, 3/2/2023
Prospectus filed pursuant to Rule 424(b)(2)
FWP
Wednesday, 3/1/2023
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B2
Tuesday, 2/28/2023
Prospectus filed pursuant to Rule 424(b)(2)
SC TO-T/A
Friday, 2/24/2023
Third party tender offer statement
SC TO-T/A
Thursday, 2/23/2023
Third party tender offer statement
SC TO-T/A
Friday, 2/3/2023
Third party tender offer statement
SC TO-T
Monday, 1/23/2023
Third party tender offer statement
SC TO-C
Monday, 1/9/2023
Written communication relating to an issuer or third party tender offer
425
Wednesday, 7/14/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Wednesday, 7/14/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 7/6/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 7/6/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Wednesday, 6/30/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 6/4/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 6/4/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Thursday, 5/27/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
424B2
Thursday, 5/27/2021
Prospectus filed pursuant to Rule 424(b)(2)
FWP
Wednesday, 5/26/2021
Filing under Securities Act Rules 163/433 of free writing prospectuses
FWP
Wednesday, 5/26/2021
Filing under Securities Act Rules 163/433 of free writing prospectuses
425
Monday, 5/24/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
424B2
Monday, 5/24/2021
Prospectus filed pursuant to Rule 424(b)(2)
425
Friday, 5/7/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Thursday, 5/6/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Wednesday, 5/5/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 4/30/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 4/30/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 4/30/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Thursday, 4/29/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 4/16/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 4/16/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
424B3
Tuesday, 4/13/2021
Prospectus filed pursuant to Rule 424(b)(3)
425
Monday, 4/12/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 4/12/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Thursday, 4/1/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Thursday, 4/1/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Thursday, 4/1/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 3/12/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 2/26/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Thursday, 2/25/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 2/12/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Thursday, 2/11/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Thursday, 2/11/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Thursday, 2/11/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Thursday, 2/11/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 12/18/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Thursday, 12/17/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 12/15/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 12/14/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 12/14/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 12/14/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 12/14/2020
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
424B2
Wednesday, 8/5/2020
Prospectus filed pursuant to Rule 424(b)(2)
FWP
Tuesday, 8/4/2020
Filing under Securities Act Rules 163/433 of free writing prospectuses
FWP
Monday, 8/3/2020
Filing under Securities Act Rules 163/433 of free writing prospectuses
S-8
Monday, 8/3/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B2
Monday, 8/3/2020
Prospectus filed pursuant to Rule 424(b)(2)
424B2
Thursday, 8/16/2018
Prospectus filed pursuant to Rule 424(b)(2)
FWP
Wednesday, 8/15/2018
Filing under Securities Act Rules 163/433 of free writing prospectuses
S-8
Tuesday, 8/14/2018
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
FWP
Tuesday, 8/14/2018
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B2
Tuesday, 8/14/2018
Prospectus filed pursuant to Rule 424(b)(2)
424B2
Wednesday, 6/7/2017
Prospectus filed pursuant to Rule 424(b)(2)
FWP
Tuesday, 6/6/2017
Filing under Securities Act Rules 163/433 of free writing prospectuses
FWP
Monday, 6/5/2017
Filing under Securities Act Rules 163/433 of free writing prospectuses
FWP
Monday, 6/5/2017
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B2
Monday, 6/5/2017
Prospectus filed pursuant to Rule 424(b)(2)
S-8
Thursday, 3/23/2017
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B2
Friday, 11/13/2015
Prospectus filed pursuant to Rule 424(b)(2)
FWP
Thursday, 11/12/2015
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B2
Tuesday, 11/10/2015
Prospectus filed pursuant to Rule 424(b)(2)
425
Tuesday, 5/27/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 5/20/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 5/19/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 5/19/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 5/13/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 5/13/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 5/12/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 5/12/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 5/12/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 5/12/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Wednesday, 5/7/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 5/6/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 5/5/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 5/5/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 5/2/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 5/2/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 5/2/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 4/29/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 4/28/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 4/28/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Monday, 4/28/2014
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
424B2
Thursday, 9/13/2012
Prospectus filed pursuant to Rule 424(b)(2)
FWP
Wednesday, 9/12/2012
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B2
Tuesday, 9/11/2012
Prospectus filed pursuant to Rule 424(b)(2)
S-8
Friday, 11/5/2010
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans